$GTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PERNIX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PERNIX THERAPEUTICS HOLDINGS, INC.. Get notifications about new insider transactions in PERNIX THERAPEUTICS HOLDINGS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 08 2019 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | SVP, GC,Compliance ... | Payment of Exercise | F | 0.45 | 417 | 187 | 14,726 | 15.1 K to 14.7 K (-2.75 %) |
Aug 10 2018 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | SVP, GC & Complianc ... | Payment of Exercise | F | 1.86 | 411 | 764 | 15,143 | 15.6 K to 15.1 K (-2.64 %) |
Aug 10 2018 | GTA | PERNIX THERAPEUTIC ... | Whaley Glenn | VP of Fin, PAO & Co ... | Payment of Exercise | F | 1.86 | 84 | 156 | 3,616 | 3.7 K to 3.6 K (-2.27 %) |
Aug 10 2018 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Chairman of Board a ... | Payment of Exercise | F | 1.86 | 685 | 1,274 | 133,140 | 133.8 K to 133.1 K (-0.51 %) |
Aug 10 2018 | GTA | PERNIX THERAPEUTIC ... | Smith Angus W. | SVP, CBO & Principa ... | Payment of Exercise | F | 1.86 | 282 | 525 | 8,018 | 8.3 K to 8 K (-3.40 %) |
Jul 27 2018 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Chairman of Board a ... | Payment of Exercise | F | 2.53 | 11,982 | 30,314 | 133,825 | 145.8 K to 133.8 K (-8.22 %) |
May 23 2018 | GTA | PERNIX THERAPEUTIC ... | Swirsky Douglas J | Director | Option Exercise | A | 2.63 | 25,000 | 65,750 | 25,000 | |
May 23 2018 | GTA | PERNIX THERAPEUTIC ... | Leone John R | Director | Option Exercise | A | 2.63 | 25,000 | 65,750 | 25,000 | |
May 23 2018 | GTA | PERNIX THERAPEUTIC ... | LANGER DENNIS | Director | Option Exercise | A | 2.63 | 25,000 | 65,750 | 25,000 | |
May 23 2018 | GTA | PERNIX THERAPEUTIC ... | LEUNG GABRIEL | Director | Option Exercise | A | 2.63 | 25,000 | 65,750 | 25,000 | |
Apr 09 2018 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | SVP, GC & Complianc ... | Payment of Exercise | F | 2.74 | 446 | 1,222 | 15,554 | 16 K to 15.6 K (-2.79 %) |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Smith Angus W. | SVP, Chief Bus Off ... | Option Exercise | A | 2.46 | 15,000 | 36,900 | 15,000 | |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Smith Angus W. | SVP, Chief Bus Off ... | Grant | A | 0.00 | 5,000 | 0 | 8,300 | 3.3 K to 8.3 K (+151.52 %) |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | SVP, GC & Complianc ... | Option Exercise | A | 2.46 | 15,000 | 36,900 | 15,000 | |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | SVP, GC & Complianc ... | Grant | A | 0.00 | 5,000 | 0 | 16,000 | 11 K to 16 K (+45.45 %) |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Whaley Glenn | Interim VP Fin, PAO ... | Option Exercise | A | 2.46 | 7,800 | 19,188 | 7,800 | |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Whaley Glenn | Interim VP Fin, PAO ... | Grant | A | 0.00 | 2,600 | 0 | 3,700 | 1.1 K to 3.7 K (+236.36 %) |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Chairman of the Boa ... | Option Exercise | A | 2.46 | 64,000 | 157,440 | 64,000 | |
Mar 16 2018 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Chairman of the Boa ... | Grant | A | 0.00 | 18,000 | 0 | 145,807 | 127.8 K to 145.8 K (+14.08 %) |
Nov 17 2017 | GTA | PERNIX THERAPEUTIC ... | LANGER DENNIS | Director | Option Exercise | A | 2.97 | 50,000 | 148,500 | 50,000 | |
Nov 17 2017 | GTA | PERNIX THERAPEUTIC ... | LEUNG GABRIEL | Director | Option Exercise | A | 2.97 | 50,000 | 148,500 | 50,000 | |
Nov 17 2017 | GTA | PERNIX THERAPEUTIC ... | Leone John R | Director | Option Exercise | A | 2.97 | 50,000 | 148,500 | 50,000 | |
Nov 17 2017 | GTA | PERNIX THERAPEUTIC ... | Swirsky Douglas J | Director | Option Exercise | A | 2.97 | 50,000 | 148,500 | 50,000 | |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Golembiewski Michael Joseph | VP Finance, Control ... | Option Exercise | A | 2.92 | 10,000 | 29,200 | 10,000 | |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Golembiewski Michael Joseph | VP Finance, Control ... | Grant | A | 0.00 | 3,300 | 0 | 3,300 | 0 to 3.3 K |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | SVP, Gen Counsel & ... | Option Exercise | A | 2.78 | 18,000 | 50,040 | 18,000 | |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | SVP, Gen Counsel & ... | Grant | A | 0.00 | 6,000 | 0 | 11,000 | 5 K to 11 K (+120.00 %) |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Miao Graham G | President and CFO | Option Exercise | A | 2.78 | 20,000 | 55,600 | 20,000 | |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Miao Graham G | President and CFO | Grant | A | 0.00 | 6,667 | 0 | 64,035 | 57.4 K to 64 K (+11.62 %) |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Chairman of Board a ... | Option Exercise | A | 2.78 | 30,000 | 83,400 | 30,000 | |
Aug 09 2017 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Chairman of Board a ... | Grant | A | 0.00 | 10,000 | 0 | 127,807 | 117.8 K to 127.8 K (+8.49 %) |
Jul 31 2017 | GTA | PERNIX THERAPEUTIC ... | Miao Graham G | President and CFO | Payment of Exercise | F | 3.15 | 8,132 | 25,616 | 57,368 | 65.5 K to 57.4 K (-12.42 %) |
Jul 31 2017 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Board Chairman and ... | Payment of Exercise | F | 3.15 | 13,293 | 41,873 | 117,807 | 131.1 K to 117.8 K (-10.14 %) |
Jan 17 2017 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | S VP, Gen Counsel a ... | Option Exercise | A | 2.10 | 15,000 | 31,500 | 15,000 | |
Jan 17 2017 | GTA | PERNIX THERAPEUTIC ... | Pina Kenneth | S VP, Gen Counsel a ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Nov 22 2016 | GTA | PERNIX THERAPEUTIC ... | LEUNG GABRIEL | Director | Option Exercise | A | 3.50 | 4,000 | 14,000 | 4,000 | |
Nov 08 2016 | GTA | PERNIX THERAPEUTIC ... | LANGER DENNIS | Director | Option Exercise | A | 3.15 | 4,000 | 12,600 | 4,000 | |
Nov 07 2016 | GTA | PERNIX THERAPEUTIC ... | Miao Graham G | PRESIDENT AND CFO | Option Exercise | A | 3.15 | 95,000 | 299,250 | 95,000 | |
Nov 07 2016 | GTA | PERNIX THERAPEUTIC ... | Miao Graham G | PRESIDENT AND CFO | Grant | A | 0.00 | 65,500 | 0 | 65,500 | 0 to 65.5 K |
Nov 07 2016 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | CHAIRMAN OF THE BOA ... | Option Exercise | A | 3.36 | 40,000 | 134,400 | 40,000 | |
Nov 07 2016 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | CHAIRMAN OF THE BOA ... | Option Exercise | A | 3.15 | 150,000 | 472,500 | 150,000 | |
Nov 07 2016 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | CHAIRMAN OF THE BOA ... | Grant | A | 0.00 | 131,100 | 0 | 131,100 | 0 to 131.1 K |
May 31 2016 | GTA | PERNIX THERAPEUTIC ... | Konidaris Tasos | Director | Option Exercise | A | 0.45 | 40,000 | 18,000 | 40,000 | |
May 31 2016 | GTA | PERNIX THERAPEUTIC ... | ELMS STEVE | Director | Option Exercise | P | 0.45 | 40,000 | 18,000 | 0 | |
May 11 2016 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Interim CEO | Option Exercise | A | 0.52 | 210,000 | 109,200 | 210,000 | |
Feb 29 2016 | GTA | PERNIX THERAPEUTIC ... | Patel Sanjay S | Chief Financial Off ... | Option Exercise | A | 2.14 | 350,000 | 749,000 | 350,000 | |
Feb 29 2016 | GTA | PERNIX THERAPEUTIC ... | Golembiewski Michael Joseph | VP Finance, Control ... | Option Exercise | A | 2.14 | 65,000 | 139,100 | 65,000 | |
Feb 29 2016 | GTA | PERNIX THERAPEUTIC ... | Shalaby Rick | SVP Commercial Oper ... | Option Exercise | A | 2.14 | 100,000 | 214,000 | 100,000 | |
Feb 29 2016 | GTA | PERNIX THERAPEUTIC ... | Drysdale Douglas | Chief Executive Off ... | Option Exercise | A | 2.14 | 450,000 | 963,000 | 450,000 | |
Feb 29 2016 | GTA | PERNIX THERAPEUTIC ... | Novak Terence | Chief Operating Off ... | Option Exercise | A | 2.14 | 100,000 | 214,000 | 100,000 | |
Feb 29 2016 | GTA | PERNIX THERAPEUTIC ... | Siegel Barry J | Senior VP and Gener ... | Option Exercise | A | 2.14 | 200,000 | 428,000 | 200,000 | |
Aug 20 2015 | GTA | PERNIX THERAPEUTIC ... | Siegel Barry J | Senior VP and Gener ... | Buy | P | 4.49 | 5,000 | 22,450 | 5,000 | 0 to 5 K |
Aug 19 2015 | GTA | PERNIX THERAPEUTIC ... | Siegel Barry J | Senior VP and Gener ... | Option Exercise | A | 4.70 | 100,000 | 470,000 | 100,000 | |
Aug 19 2015 | GTA | PERNIX THERAPEUTIC ... | Patel Sanjay S | Chief Financial Off ... | Buy | P | 4.60 | 5,000 | 23,000 | 7,000 | 2 K to 7 K (+250.00 %) |
Aug 19 2015 | GTA | PERNIX THERAPEUTIC ... | Drysdale Douglas | Chief Executive Off ... | Buy | P | 4.69 | 8,500 | 39,857 | 95,161 | 86.7 K to 95.2 K (+9.81 %) |
Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | Drysdale Douglas | Chief Executive Off ... | Option Exercise | A | 4.70 | 360,000 | 1,692,000 | 360,000 | |
Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | Novak Terence | Chief Operating Off ... | Option Exercise | A | 4.70 | 120,000 | 564,000 | 120,000 | |
Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | Shalaby Rick | SVP of Commercial O ... | Option Exercise | A | 4.70 | 120,000 | 564,000 | 120,000 | |
Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | Patel Sanjay S | Chief Financial Off ... | Option Exercise | A | 4.70 | 120,000 | 564,000 | 120,000 | |
Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Director | Option Exercise | A | 4.70 | 40,000 | 188,000 | 40,000 | |
Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | Konidaris Tasos | Director | Option Exercise | A | 4.70 | 40,000 | 188,000 | 40,000 | |
Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | ELMS STEVE | Director | Option Exercise | P | 4.70 | 40,000 | 188,000 | 40,000 | |
Jun 01 2015 | GTA | PERNIX THERAPEUTIC ... | Golembiewski Michael Joseph | VP Finance, Control ... | Option Exercise | A | 10.51 | 60,000 | 630,600 | 0 | |
May 06 2015 | GTA | PERNIX THERAPEUTIC ... | Drysdale Douglas | Chief Executive Off ... | Buy | P | 6.40 | 16,000 | 102,397 | 96,661 | 80.7 K to 96.7 K (+19.84 %) |
May 06 2015 | GTA | PERNIX THERAPEUTIC ... | Patel Sanjay S | Chief Financial Off ... | Buy | P | 6.42 | 2,000 | 12,840 | 2,000 | 0 to 2 K |
Apr 24 2015 | GTA | PERNIX THERAPEUTIC ... | ELMS STEVE | Director | Option Exercise | P | 11.47 | 2,500,000 | 28,675,000 | 2,500,000 | |
Nov 20 2014 | GTA | PERNIX THERAPEUTIC ... | Shalaby Rick | SVP Sales | Option Exercise | A | 9.31 | 200,000 | 1,862,000 | 0 | |
Nov 04 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Option Exercise | M | 3.80 | 2,246 | 8,535 | 0 | |
Nov 04 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Sell | S | 10.00 | 2,246 | 22,460 | 7,506 | 9.8 K to 7.5 K (-23.03 %) |
Nov 04 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Buy | M | 3.80 | 2,246 | 8,535 | 9,752 | 7.5 K to 9.8 K (+29.92 %) |
Oct 30 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Option Exercise | M | 3.80 | 12,754 | 48,465 | 2,246 | |
Oct 30 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Sell | S | 10.00 | 12,754 | 127,540 | 6,981 | 19.7 K to 7 K (-64.63 %) |
Oct 30 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Buy | M | 3.80 | 12,754 | 48,465 | 19,735 | 7 K to 19.7 K (+182.70 %) |
Oct 10 2014 | GTA | PERNIX THERAPEUTIC ... | Dorsey Brian | SVP Research | Grant | A | 0.00 | 50,000 | 0 | 87,426 | 37.4 K to 87.4 K (+133.60 %) |
Oct 10 2014 | GTA | PERNIX THERAPEUTIC ... | Dorsey Brian | SVP Research | Grant | A | 0.00 | 33,333 | 0 | 62,426 | 29.1 K to 62.4 K (+114.57 %) |
Oct 06 2014 | GTA | PERNIX THERAPEUTIC ... | Shalaby Rick | SVP Commercial Oper ... | Option Exercise | A | 7.01 | 50,000 | 350,500 | 0 | |
Aug 12 2014 | GTA | PERNIX THERAPEUTIC ... | Drysdale Douglas | Chief Executive Off ... | Option Exercise | M | 2.09 | 187,500 | 391,875 | 0 | |
Aug 12 2014 | GTA | PERNIX THERAPEUTIC ... | Drysdale Douglas | Chief Executive Off ... | Sell | D | 6.67 | 106,839 | 712,616 | 80,661 | 187.5 K to 80.7 K (-56.98 %) |
Aug 12 2014 | GTA | PERNIX THERAPEUTIC ... | Drysdale Douglas | Chief Executive Off ... | Buy | M | 2.09 | 187,500 | 391,875 | 187,500 | 0 to 187.5 K |
Jul 03 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Buy | S | 9.01 | 300 | 2,703 | 221,647 | 221.3 K to 221.6 K (+0.14 %) |
Jul 03 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Sell | S | 9.01 | 400 | 3,602 | 221,647 | 222 K to 221.6 K (-0.18 %) |
Jul 03 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Sell | S | 9.00 | 14,300 | 128,700 | 221,647 | 235.9 K to 221.6 K (-6.06 %) |
Jun 24 2014 | GTA | PERNIX THERAPEUTIC ... | Patel Sanjay S | Chief Financial Off ... | Option Exercise | A | 8.63 | 500,000 | 4,315,000 | 500,000 | |
Jun 20 2014 | GTA | PERNIX THERAPEUTIC ... | ELMS STEVE | Director | Option Exercise | P | 8.26 | 40,000 | 330,400 | 40,000 | |
May 21 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 6.07 | 30,000 | 182,178 | 3,498,504 | 3.5 M to 3.5 M (-0.85 %) |
May 21 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 6.08 | 45,000 | 273,776 | 3,528,504 | 3.6 M to 3.5 M (-1.26 %) |
May 21 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 6.16 | 119,600 | 736,581 | 3,573,504 | 3.7 M to 3.6 M (-3.24 %) |
May 16 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 6.38 | 60,200 | 383,859 | 3,693,104 | 3.8 M to 3.7 M (-1.60 %) |
May 16 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 6.06 | 250,000 | 1,514,750 | 3,753,304 | 4 M to 3.8 M (-6.24 %) |
May 14 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.59 | 253,581 | 1,417,011 | 4,003,304 | 4.3 M to 4 M (-5.96 %) |
May 14 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.33 | 15,000 | 64,989 | 4,256,885 | 4.3 M to 4.3 M (-0.35 %) |
May 14 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.82 | 20,819 | 100,312 | 4,271,885 | 4.3 M to 4.3 M (-0.48 %) |
May 09 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.57 | 15,000 | 68,577 | 4,292,704 | 4.3 M to 4.3 M (-0.35 %) |
May 09 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.36 | 15,000 | 65,381 | 4,307,704 | 4.3 M to 4.3 M (-0.35 %) |
May 09 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.18 | 15,000 | 62,639 | 4,322,704 | 4.3 M to 4.3 M (-0.35 %) |
May 06 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.37 | 15,000 | 65,505 | 4,337,704 | 4.4 M to 4.3 M (-0.34 %) |
May 06 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.44 | 15,000 | 66,636 | 4,352,704 | 4.4 M to 4.4 M (-0.34 %) |
May 06 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.51 | 15,000 | 67,718 | 4,367,704 | 4.4 M to 4.4 M (-0.34 %) |
May 01 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.63 | 15,000 | 69,486 | 4,382,704 | 4.4 M to 4.4 M (-0.34 %) |
May 01 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.72 | 15,000 | 70,790 | 4,397,704 | 4.4 M to 4.4 M (-0.34 %) |
Apr 29 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.86 | 15,000 | 72,918 | 4,412,704 | 4.4 M to 4.4 M (-0.34 %) |
Apr 29 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.91 | 15,000 | 73,577 | 4,427,704 | 4.4 M to 4.4 M (-0.34 %) |
Apr 29 2014 | GTA | PERNIX THERAPEUTIC ... | Konidaris Tasos | Director | Option Exercise | A | 5.28 | 40,000 | 211,200 | 40,000 | |
Apr 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.10 | 15,000 | 76,446 | 4,442,704 | 4.5 M to 4.4 M (-0.34 %) |
Apr 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.31 | 15,000 | 79,626 | 4,457,704 | 4.5 M to 4.5 M (-0.34 %) |
Apr 24 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Buy | S | 4.98 | 15,000 | 74,636 | 4,472,704 | 4.5 M to 4.5 M (+0.34 %) |
Apr 24 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Buy | S | 4.91 | 15,000 | 73,695 | 4,487,704 | 4.5 M to 4.5 M (+0.34 %) |
Apr 17 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.43 | 5,000 | 22,152 | 4,502,704 | 4.5 M to 4.5 M (-0.11 %) |
Apr 17 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.33 | 15,000 | 64,892 | 4,507,704 | 4.5 M to 4.5 M (-0.33 %) |
Apr 15 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.26 | 15,000 | 63,948 | 4,522,704 | 4.5 M to 4.5 M (-0.33 %) |
Apr 15 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.62 | 15,000 | 69,347 | 4,537,704 | 4.6 M to 4.5 M (-0.33 %) |
Apr 15 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.99 | 15,000 | 74,895 | 4,552,704 | 4.6 M to 4.6 M (-0.33 %) |
Apr 10 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.01 | 15,000 | 75,195 | 4,567,704 | 4.6 M to 4.6 M (-0.33 %) |
Apr 10 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.23 | 15,000 | 78,491 | 4,582,704 | 4.6 M to 4.6 M (-0.33 %) |
Apr 10 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.83 | 15,000 | 72,501 | 4,597,704 | 4.6 M to 4.6 M (-0.33 %) |
Apr 07 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.85 | 15,000 | 72,726 | 4,612,704 | 4.6 M to 4.6 M (-0.32 %) |
Apr 07 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.84 | 15,000 | 72,585 | 4,627,704 | 4.6 M to 4.6 M (-0.32 %) |
Apr 07 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.03 | 15,000 | 75,390 | 4,642,704 | 4.7 M to 4.6 M (-0.32 %) |
Apr 02 2014 | GTA | PERNIX THERAPEUTIC ... | Collins Cooper C. | Chief Strategic Off ... | Sell | S | 5.19 | 23,898 | 124,131 | 2,500,046 | 2.5 M to 2.5 M (-0.95 %) |
Apr 02 2014 | GTA | PERNIX THERAPEUTIC ... | Collins Cooper C. | Chief Strategic Off ... | Sell | S | 5.28 | 66,102 | 348,952 | 2,523,944 | 2.6 M to 2.5 M (-2.55 %) |
Apr 02 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.14 | 15,000 | 77,085 | 4,657,704 | 4.7 M to 4.7 M (-0.32 %) |
Apr 02 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.25 | 15,000 | 78,761 | 4,672,704 | 4.7 M to 4.7 M (-0.32 %) |
Apr 02 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.39 | 15,000 | 80,813 | 4,687,704 | 4.7 M to 4.7 M (-0.32 %) |
Mar 28 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.42 | 15,000 | 81,270 | 4,702,704 | 4.7 M to 4.7 M (-0.32 %) |
Mar 28 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.46 | 15,000 | 81,954 | 4,717,704 | 4.7 M to 4.7 M (-0.32 %) |
Mar 28 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.52 | 15,000 | 82,796 | 4,732,704 | 4.7 M to 4.7 M (-0.32 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.73 | 15,000 | 85,946 | 4,747,704 | 4.8 M to 4.7 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.71 | 15,000 | 85,580 | 4,762,704 | 4.8 M to 4.8 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.51 | 15,000 | 82,620 | 4,777,704 | 4.8 M to 4.8 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 5.31 | 15,000 | 79,593 | 4,792,704 | 4.8 M to 4.8 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.75 | 15,000 | 71,253 | 4,807,704 | 4.8 M to 4.8 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 4.32 | 15,000 | 64,839 | 4,822,704 | 4.8 M to 4.8 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.62 | 15,000 | 54,369 | 4,837,704 | 4.9 M to 4.8 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.63 | 15,000 | 54,522 | 4,852,704 | 4.9 M to 4.9 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.68 | 15,000 | 55,157 | 4,867,704 | 4.9 M to 4.9 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.66 | 15,000 | 54,873 | 4,882,704 | 4.9 M to 4.9 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.78 | 15,000 | 56,663 | 4,897,704 | 4.9 M to 4.9 M (-0.31 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.70 | 15,000 | 55,496 | 4,912,704 | 4.9 M to 4.9 M (-0.30 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.68 | 15,000 | 55,227 | 4,927,704 | 4.9 M to 4.9 M (-0.30 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.70 | 15,000 | 55,551 | 4,942,704 | 5 M to 4.9 M (-0.30 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.57 | 15,000 | 53,513 | 4,957,704 | 5 M to 5 M (-0.30 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.57 | 15,000 | 53,492 | 4,972,704 | 5 M to 5 M (-0.30 %) |
Mar 25 2014 | GTA | PERNIX THERAPEUTIC ... | Smith James Edward Jr. | 10% Owner | Sell | S | 3.59 | 15,000 | 53,807 | 4,987,704 | 5 M to 5 M (-0.30 %) |
Mar 19 2014 | GTA | PERNIX THERAPEUTIC ... | Shalaby Rick | SVP Sales | Option Exercise | A | 3.49 | 100,000 | 349,000 | 100,000 | |
Mar 14 2014 | GTA | PERNIX THERAPEUTIC ... | Sedor John A | Director | Option Exercise | A | 3.74 | 40,000 | 149,600 | 40,000 | |
Mar 11 2014 | GTA | PERNIX THERAPEUTIC ... | Novak Terence | Chief Operating Off ... | Grant | A | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Mar 05 2014 | GTA | PERNIX THERAPEUTIC ... | Collins Cooper C. | Chief Strategic Off ... | Sell | S | 3.40 | 3,500,000 | 11,900,000 | 2,590,046 | 6.1 M to 2.6 M (-57.47 %) |
Mar 05 2014 | GTA | PERNIX THERAPEUTIC ... | Collins Cooper C. | Chief Strategic Off ... | Sell | S | 3.59 | 47,195 | 169,222 | 6,090,046 | 6.1 M to 6.1 M (-0.77 %) |
Mar 05 2014 | GTA | PERNIX THERAPEUTIC ... | Collins Cooper C. | Chief Strategic Off ... | Sell | S | 3.61 | 42,805 | 154,547 | 6,137,241 | 6.2 M to 6.1 M (-0.69 %) |
Feb 13 2014 | GTA | PERNIX THERAPEUTIC ... | Clifford Tracy Simmons | Principal Accountin ... | Grant | A | 0.00 | 100,000 | 0 | 122,563 | 22.6 K to 122.6 K (+443.20 %) |